Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002002579 | SCV002247779 | likely benign | Noonan syndrome 9 | 2022-11-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003375503 | SCV004096319 | uncertain significance | Cardiovascular phenotype | 2023-06-22 | criteria provided, single submitter | clinical testing | The p.L777F variant (also known as c.2329C>T), located in coding exon 14 of the SOS2 gene, results from a C to T substitution at nucleotide position 2329. The leucine at codon 777 is replaced by phenylalanine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |